denbufylline has been researched along with thromboxane a2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cieslinski, LB; Michell, MP; Ohlstein, EH; Sauermelch, CF; Shiloh, AO; Sulpizio, A; Torphy, TJ; Willette, RN | 1 |
1 other study(ies) available for denbufylline and thromboxane a2
Article | Year |
---|---|
Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Basilar Artery; Cerebral Arteries; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dogs; Drug Evaluation, Preclinical; Ischemic Attack, Transient; Isoenzymes; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Prostaglandin Endoperoxides, Synthetic; Pyrrolidinones; Rolipram; Second Messenger Systems; Subarachnoid Hemorrhage; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents; Xanthines | 1997 |